Reprocessing of reusable medical devices
医疗器械行业正面临着新的考验es and adopting new technology advancement this industry has so many opportunities which can be advantageous for us. This article is based on a few reports and it is about the US Market.再生医疗器械是一步一步的过程ss to disinfect the used device. For the safety of the patient and to avoid the risk of infection reusable devices undergo reprocessing. It is a multistep process to clean and disinfect the medical device.When used on patients, reusable devices become dirty and contaminated with microorganisms. To keep away from any danger of infection by a contaminated tool, reusable devices go through “reprocessing,” an in depth, multistep process which disinfects or sterilizes them.
When the labeling instructions for reprocessing are completely and correctly followed after every use of the device, reprocessing results in a medical device that can be safely used more than once in a couple of patients. Reprocessing reusable medical devices is important to protect patients’ safety. Examples of reusable reprocessed devices are surgical forceps, stethoscopes,Etc.
US FDA issued a guidance which provides recommendations on reprocessing instructions for reusable medical devices.This guidance document also provides recommendations for the content and review of premarket notification submissions [510(k)], premarket approval (PMA) applications, humanitarian device exemption (HDE) applications, de novo requests and investigational device exemption (IDE) applications, concerning the labelling instructions for reprocessing reusable medical devices.We help our clients inFDA 510 (k) clearanceprocess and provide various regulatory services .to avail our servicescontact usorwhatsapp usyour requirement .
Increasing wide variety of hospitals with well-equipped medical devices & surgical devices, rising FDA approvals for reprocessed cardiovascular products, growing desire of healthcare professionals toward single use reprocessed devices (SUDc) are contributing to the growth of global reprocessed medical devices market.
Recently the AMDR (Association of Medical Device Reprossers) shared “Global Regulatory Standards for ‘Single-Use’ Medical Device Reprocessing and Remanufacturing”this will help Notified bodies, Ministries of health and regulatory authorities in unlocking the benefits for the hospitals and health system worldwide.
USFDA was the first regulatory body to create the regulatory pathway for commercial SUDs reprocessing for the world. Today many SUDs are reprocessed and reused safely. The benefit of reprocessing is the reduction in cost and waste, increase in quality, and strengthen the supply chain.
After Covid-19 pandemic, Global medical device reprocessing market is projected to reach a revised size of US$3.3 Billion by 2026.The pandemic situation changed the way people used to live earlier. Now people become more aware about health, health practitioners also redesigned their way to treat the patients. Covid-19 pandemic badly hurted the world in hardest way, During Covid-19 we have seen that test kits played key role in preventing the spread of pandemic.
Global medical device reprocessing market is expected to grow and to become part of this growing market one need to know the updated regulations and guidance. Operon strategistmedical device regulatory consultancyprovide guidance to the manufacturer on their regulatory need. To read more medical device regulatory updates download ourNewsletter!
